[Renin-angiotensin system blockade reduces cardiovascular mortality and morbidity attributable to arterial hypertension by primary and secondary prevention. The end of the road?]

Med Clin (Barc). 2000 Jul 1;115(5):178-80. doi: 10.1016/s0025-7753(00)71500-4.
[Article in Spanish]
No abstract available

Publication types

  • Comparative Study
  • Editorial
  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use*
  • Captopril / administration & dosage
  • Captopril / therapeutic use
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / mortality
  • Cardiovascular Diseases / prevention & control*
  • Clinical Trials as Topic
  • Diabetes Complications
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetic Nephropathies / prevention & control
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy*
  • Hypertension / prevention & control
  • Kidney Diseases / prevention & control
  • Primary Prevention
  • Randomized Controlled Trials as Topic
  • Renin-Angiotensin System / drug effects*
  • Risk Factors
  • Time Factors

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Captopril